Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test Systems Enters Exclusive U.K. and Ireland Distribution Agreement with Luas Diagnostics HAUPPAUGE, NY, January 14, 2021
New Covid-19 tests to be distributed in UK by Luas Diagnostics following exclusive agreement Two new rapid antibody and antigen tests for Covid-19 from the US will be distributed
Luas Diagnostics (LD) has signed an option agreement with Molecular Warehouse (MW) of Guildford, Surrey. Under the terms of the agreement MW, who are a 49% shareholder in LD, will
Luas Diagnostics and the University of Birmingham to collaborate on development of a saliva-based rapid test for COVID-19 antigen
A saliva-based test for COVID-19 providing results directly to patients in minutes is being developed as a result of a new collaboration between Luas Diagnostics and the University of Birmingham.